Literature DB >> 17501665

Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells.

Cécile Lambert1, Cécile Oury, Emmanuel Dejardin, Alain Chariot, Jacques Piette, Michel Malaise, Marie-Paule Merville, Nathalie Franchimont.   

Abstract

UNLABELLED: The mechanisms of IL-1beta stimulation of OPG were studied in more detail. Whereas p38 and ERK activation was confirmed to be needed, NF-kappaB was not necessary for this regulation. We also found that OPG production after IL-1beta stimulation was not sufficient to block TRAIL-induced apoptosis in MG-63 cells.
INTRODUCTION: Osteoprotegerin (OPG) plays a key role in the regulation of bone resorption and is stimulated by interleukin (IL)-1beta. Herein, we defined the mechanisms of IL-1beta stimulation of OPG focusing on the potential involvement of MAPK and NF-kappaB. We also examined whether OPG production in response to IL-1beta influences TRAIL-induced apoptosis in MG-63 cells.
MATERIALS AND METHODS: OPG mRNA levels in MG-63 cells were quantified by real-time RT-PCR and protein levels of OPG and IL-6 by ELISA. Cell viability was assessed using the methyltetrazidium salt (MTS) reduction assay. The role of the MAPK pathway was studied by both Western blotting and the use of specific chemical inhibitors. NF-kappaB function was studied using BAY 11-7085 and by siRNA transfection to inhibit p65 synthesis. Transcription mechanisms were analyzed by transiently transfecting MG-63 cells with OPG promoter constructs. Post-transcriptional effects were examined by using cycloheximide and actinomycin D.
RESULTS: MG-63 cells treatment with IL-1beta resulted in the phosphorylation of c-Jun NH(2)-terminal kinase (JNK), p38, and extracellular signal-regulated kinase (ERK). The use of the specific inhibitors showed that p38 and ERK but not JNK were needed for IL-1beta-induced OPG production. In contrast, NF-kappaB was not essential for IL-1beta induction of OPG. We also showed a small transcriptional and a possible post-transcriptional or translational regulation of OPG by IL-1beta. Exogenous OPG blocked TRAIL-induced apoptosis, but IL-1beta induction of OPG did not influence TRAIL-induced cell death.
CONCLUSIONS: IL-1beta stimulates OPG production by mechanisms dependent on p38 and ERK. In contrast, NF-kappaB was not essential for this regulation. Although the relevance of IL-1beta stimulation of OPG is still not fully understood, our data showed that IL-1beta stimulation of OPG does not modify TRAIL-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17501665     DOI: 10.1359/jbmr.070508

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

1.  From the Cover: Embryonic Exposure to TCDD Impacts Osteogenesis of the Axial Skeleton in Japanese medaka, Oryzias latipes.

Authors:  AtLee T D Watson; Antonio Planchart; Carolyn J Mattingly; Christoph Winkler; David M Reif; Seth W Kullman
Journal:  Toxicol Sci       Date:  2016-11-15       Impact factor: 4.849

2.  Differential effects of p38MAP kinase inhibitors on the expression of inflammation-associated genes in primary, interleukin-1beta-stimulated human chondrocytes.

Authors:  H Joos; W Albrecht; S Laufer; R E Brenner
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 3.  Do RANKL inhibitors (denosumab) affect inflammation and immunity?

Authors:  S Ferrari-Lacraz; S Ferrari
Journal:  Osteoporos Int       Date:  2010-06-23       Impact factor: 4.507

4.  Action of IL-1beta during fracture healing.

Authors:  Jeffrey Lange; Anna Sapozhnikova; Chuanyong Lu; Diane Hu; Xin Li; Theodore Miclau; Ralph S Marcucio
Journal:  J Orthop Res       Date:  2010-06       Impact factor: 3.494

5.  The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis.

Authors:  Kosuke Ebina; Jun Hashimoto; Masafumi Kashii; Makoto Hirao; Shoichi Kaneshiro; Takaaki Noguchi; Yasunori Tsukamoto; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2016-01-13       Impact factor: 2.626

6.  Calreticulin inhibits inflammation-induced osteoclastogenesis and bone resorption.

Authors:  Charla R Fischer; Maya Mikami; Hiroshi Minematsu; Saqib Nizami; Heon Goo Lee; Danielle Stamer; Neel Patel; Do Yu Soung; Jung-Ho Back; Lee Song; Hicham Drissi; Francis Y Lee
Journal:  J Orthop Res       Date:  2017-07-18       Impact factor: 3.494

7.  Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells.

Authors:  Stephanie Tsang Mui Chung; Dirk Geerts; Kim Roseman; Ashleigh Renaud; Linda Connelly
Journal:  Mol Cancer       Date:  2017-02-01       Impact factor: 27.401

8.  Transglutaminase-2 Is Involved in Expression of Osteoprotegerin in MG-63 Osteosarcoma Cells.

Authors:  Hye Ja Lee; Chang Hoon Lee
Journal:  Biomol Ther (Seoul)       Date:  2013-05-30       Impact factor: 4.634

Review 9.  p38 MAPK Signaling in Osteoblast Differentiation.

Authors:  Eddie Rodríguez-Carballo; Beatriz Gámez; Francesc Ventura
Journal:  Front Cell Dev Biol       Date:  2016-05-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.